Product Comparison


 
Seqirus USA Inc 33332042110
Seqirus USA Inc 33332022120
Medimmune 66019030810
McKesson # 1183078 1183072 1182039
Description Afluria® Quadrivalent 2021 - 2022 Flu Vaccine 60 mcg / 0.5 mL Indicated for People 6 Months of Age and Above Multiple Dose Vial 5 mL Afluria® Quadrivalent 2021 - 2022 Pediatric Flu Vaccine 30 mcg / 0.25 mL Indicated For People 6 Months to 35 Months of Age Prefilled Syringe 0.25 mL FluMist® Quadrivalent 2021 - 2022 Flu Vaccine 10E6.5 - 7.5 FFU Indicated For People 2 to 49 Years of Age Intranasal Sprayer 0.2 mL
Manufacturer # 333320421103333202212066019030810
Brand Afluria® Quadrivalent 2021 - 2022Afluria® Quadrivalent 2021 - 2022 PediatricFluMist® Quadrivalent 2021 - 2022
Manufacturer Seqirus USA IncSeqirus USA IncMedimmune
Invoice AFLURIA 2021, QUAD MDV 5ML (10DOSE/VL)AFLURIA 2021, QUAD SYR PED 0.25ML (10DOSE/BX)FLUMIST QUAD 2021, SPR (10DOSE/BX)
    Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 15864781586551
Container Type Multiple Dose VialPrefilled SyringeIntranasal Sprayer
Country of Origin AustraliaAustraliaUnited States
Dosage Form InjectionInjectionSpray
Generic Drug Code 4958349796
NDC Number 33332-0421-1033332-0221-2066019-0308-10
Strength 60 mcg / 0.5 mL30 mcg / 0.25 mL10E6.5 - 7.5 FFU
Type IntramuscularIntramuscularIntranasal
User Indicated For People 6 Months of Age and AboveIndicated For People 6 Months to 35 Months of AgeIndicated For People 2 to 49 Years of Age
Volume 5 mL0.25 mL0.2 mL
Application Flu VaccineFlu VaccineFlu Vaccine
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires Refrigeration
UNSPSC Code 512016085120160851201608
Features and Benefits
  • AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • AFLURIA QUADRIVALENT is approved for use in persons 6 Months and older
  • The multi-dose presentation contains thimerosal added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury
  • AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2021 - 2022 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2020 - 2021 Northern Hemisphere influenza season:
  • A/Brisbane/02/2018 (IVR-190) (an A/Brisbane/02/2018 (H1N1)pdm09 – like virus), A/Kansas/14/2017 (X-327) (an A/Kansas/14/2017 (H3N2) – like virus), B/Maryland/15/2016 (a B/Colorado/06/2017 – like virus) and B/Phuket/3073/2013 BVR-1B (a B/Phuket/3073/2013 – like virus). A 0.25 mL dose contains 7.5 mcg HA of each of the same four influenza strains.
  • AFLURIA® QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • 5 mL multi-dose vial ( for persons 6 months of age and older).
  • AFLURIA QUADRIVALENT is a sterile suspension for intramuscular injection
  • AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2021 - 2022 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2020 - 2021 Northern Hemisphere influenza season:
  • A/Brisbane/02/2018 (IVR-190) (an A/Brisbane/02/2018 (H1N1)pdm09 – like virus), A/Kansas/14/2017 (X-327) (an A/Kansas/14/2017 (H3N2) – like virus), B/Maryland/15/2016 (a B/Colorado/06/2017 – like virus) and B/Phuket/3073/2013 BVR-1B (a B/Phuket/3073/2013 – like virus). A 0.25 mL dose contains 7.5 mcg HA of each of the same four influenza strains.
  • FluMist®Quadrivalent (Influenza Vaccine Live, Intranasal) is a vaccine indicated for active immunization of persons 2-49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • FluMist®Quadrivalent is for intranasal administration only
  • FluMist Quadrivalent contains 4 influenza virus strains that are weakened (A(H1N1), A(H3N2), B Yamagata lineage, and B Victoria lineage)